跳至主要内容
临床试验/NCT04345081
NCT04345081招募中不适用

Examining the Cosmetic Results and Patient Satisfaction Achieved With Skin Reducing Nipple Sparing Mastectomy of Ptotic Breast Followed by Delayed-immediate Submuscular Implant Based- Breast Reconstruction Surgery, and Comparing it to Submuscular Delayed- Immediate Implant- Based Breast Reconstruction Procedures After Skin- Sparing Mastectomy. Response-adaptive, Prospective Randomized Clinical Trial

National Institute of Oncology, Hungary1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2020年4月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
110
试验地点
1
主要终点
Oncological safety

研究概览

简要总结

This is a response-adaptive (RAR) prospective randomized study with a long-term follow-up and the aim of this clinical study is to measure with qualitative and quantitative indicators the changes in cosmetic results, quality of life and patient satisfaction after delayed- immediate breast reconstruction with standardized technique Skin Reducing Nipple sparing mastectomy, SRNSM and SSM with standardized horizontal skin incision.

According to our hypothesis, SRNSM with standardized technique on pendulous/ ptotic breasts is a safe procedure compared to SSM. It also promotes the cosmetic efficacy of SRNSM with the removal of the entire glandular tissue through avoidance of the reduction of projection, the need later nipple reconstruction surgery and of areola tattoo.

In our study we propose that compared to one of the well-known and widely investigated studied SSM, our current standardized SRNSM technique is able to perform similar oncologically safe entire gland tissue removal, with low complication rate, accommodating for adjuvant treatments. Furthermore, it may provide superior cosmetic results than SSM (NAC is not removed, projection is maintained, and there is no need for further nipple reconstruction or tattoo) with high patient satisfaction which is maintained long term.

详细描述

Introduction The indication of total breast removal is primarily the part of a correct oncological therapy, but secondly the removal of the full parenchyma can be prophylactic among high risk patients with positive genetic testing. In modern breast surgery, mastectomy means the removal of the entire glandular tissue. Surgery can be done in the absence of contraindication (eg. skin infiltration, mastitis carcinomatosis), by preserving the nipple-areola complex (NAC) and the skin layer above the parenchyma (nipple-sparing mastectomy, NSM) by removal of the whole or a part of the NAC (skin-sparing mastectomy, SSM) or by removal of the nipple but with the preservation of the areola (areola-sparing mastectomy, ASM). It is important to emphasize that similarly to the classic simplex mastectomy in the cases of SSM, ASM and NSM techniques provided by an experienced and qualified breast surgeon, the complete oncological removal of the mammary gland is done[1].

The essence of advanced mastectomy techniques is that they ensure the combination of radical oncological resection and immediate (immediate breast reconstruction, IBR) or delayed-immediate breast reconstructive surgery (delayed immediate breast reconstruction, D-IBR) (insertion of a tissue expander during the first operation, then as a second step replace it with a silicone implant). It avoids all the burden and negative effects of distant flap surgery, like donor scars, loss of movements etc. One or two-step post-mastectomy breast reconstructive surgeries are mainly implant-based techniques and less commonly autologous tissue techniques like distant pedicle flaps or free flaps. The tissue expander or silicone implant is placed primarily in a submuscular position but also can be inserted in a subcutaneous position in front of the large pectoral muscle. The coverage of the lower pole or even the entire surface of the implant may be strengthened with biological (so-called acellular dermal matrix) or synthetic materials (Ultrapro mesh) to reduce the pressure load of the implant on the preserved skin, the consequent skin perforation and so the loss of the implant.

The international literature of immediate or delayed-immediate postmastectomy breast reconstructive techniques is extensive and the correlation between these procedures and the oncological treatments (such as adjuvant radiotherapy) are well known [2]. According to the currently available evidence, reconstructive techniques do not adversely affect oncological outcome, so these breast surgical techniques are nowadays considered standard procedures in advanced breast cancer surgery[3]. Postmastectomy breast reconstruction surgeries are well-known as effective rehabilitation procedures, with significant psycho-oncological benefits to patients with low complication rates and high patient satisfaction. [4, 5]. Postmastectomy breast reconstructive surgery however require more sophisticated surgical techniques, special expertise, longer surgical time and significantly higher costs than simplex mastectomies.

Selecting the type of advanced mastectomy (SSM/NSM/ASM) of breast cancer depends on the location of the lesion, the size of the breast and its ptosis. Absolute contraindications of NSM are Paget disease of the nipple, bloody discharge, skin and nipple infiltration. Relative contraindications comprise pendolous/ptotic or large/larger sized breast and a distance between the nipple and tumor of less than 2cm. To achieve best cosmetic results, sparing the NAC became of prime importance, with widespread use of skin-sparing mastectomies. Sparing the skin layer and the NAC during removal of the entire glandular tissue promotes the efficiency of breast reconstruction by avoiding the reduction of projection, nipple reconstruction surgery and nipple tattoo. The cosmetic results and quality of life of those patients who had SSM instead of having NSM due to pendolous/ptotic breast are provenly unfavorable [6]. Numerous studies have proven that NSM with proper technique is an oncologically reliable method, hence it has become the part of several international protocols [7]. In the case of the high volume pendulous/ ptotic breasts, NSM and optimal implant-based breast reconstruction are achievable only by reduction of the skin-layer of the breast. The optimal surgical technique of skin-reducing nipple sparing mastectomy (SRNSM) has not been standardized yet. Due to the lack of high quality evidence and knowledge relating to the blood supply of NAC, safety of the procedure, complication rate, and oncological radicality the technique has not gained widespread popularity[8, 9].

Our present study validates the SRNSM operative technique, and also compares its results to that of classic SSM and delayed- immediate reconstruction in a response- adaptive prospective study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Under the age of 65 with uni- or bilateral primary breast cancer ( clinical Stage 0-III), needing skin sparing mastectomy, nipple sparing mastectomy or patients require risk reducing mastectomy independently of the axillary surgery, having immediate or delayed-immediate implant based reconstruction.

排除标准

  • In case the patient does not volunteer for the examination or the follow-ups
  • Age above 65 years or poor general health condition, where the estimated life expectancies would be less than 2 years even without the tumorous disease
  • Malignant invasive tumor in the past history (except for non-melanoma skin tumors)
  • Mastectomy and reconstruction performed due pregnancy associated breast cancer
  • Prior breast surgery (e.g. aesthetic surgery, mastopexy) and/or radiotherapy on the breast or in the axilla
  • Malignant tumor is not removed completely with pathological examination
  • Severe non-surgical (e.g. radiotherapy) complication, which could influence the aesthetic and functional results
  • Autoimmune diseases
  • Mastitis carcinomatosa
  • Lymphangitis carcinomatosa
  • Open wound therapy due SSI
  • Long-term steroid usage, which changed the skin's quality and structure
  • Patient under foster care, or psychically non-cooperative patient

结局指标

主要结局

Oncological safety

时间窗: five years of follow-up

Using correlation analysis to measure objective changes and the changes over time in oncological control achieved by different surgical techniques

Patients' satisfaction

时间窗: five years of follow-up

Using correlation analysis to measure objective changes and the changes over time in patients' satisfaction achieved by different surgical techniques

Quality of life

时间窗: five years of follow-up

Using correlation analysis to measure objective changes and the changes over time in quality of life achieved by different surgical techniques

Cosmetic results

时间窗: five years of follow-up

Using correlation analysis to measure objective changes and the changes over time in cosmetic results achieved by different surgical techniques

次要结局

  • Complications rate(five years of follow-up)

研究者

发起方
National Institute of Oncology, Hungary
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Zoltan Matrai

Head of Surgical Oncology

National Institute of Oncology, Hungary

研究点 (1)

Loading locations...

相似试验